Th17 Cell and Inflammatory Infiltrate Interactions in Cutaneous Leishmaniasis: Unraveling Immunopathogenic Mechanisms

Abraham U Morales-Primo1, Ingeborg Becker1, Claudia Patricia Pedraza-Zamora2

  • 1Laboratorio de Inmunoparasitología, Unidad de Investigación en Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México, Hospital General de México, Mexico City 06720, México.

Immune Network
|May 10, 2024
PubMed

Insights

T helper 17 (Th17) cells are crucial for controlling cutaneous leishmaniasis (CL) by recruiting immune cells. However, unchecked Th17 activity can lead to chronic CL development.

Area of Science:

  • Immunology
  • Parasitology
  • Dermatology

Background:

  • Cutaneous leishmaniasis (CL) involves complex immune cell interactions to combat Leishmania parasites.
  • CD4+ T cells orchestrate the immune response, with distinct T helper (Th) cell phenotypes influencing disease outcome.

Purpose of the Study:

  • To review the critical role of T helper 17 (Th17) cells and their interactions with the inflammatory infiltrate in cutaneous leishmaniasis.
  • To elucidate how Th17 cell activity influences the progression and resolution of CL.

Main Methods:

  • Literature review focusing on Th17 cell functions and cytokine profiles in CL.
  • Analysis of immune cell crosstalk and cytokine-mediated signaling pathways in the context of CL pathogenesis.

Main Results:

  • Th17 cells, through IL-17 release, are vital for initiating inflammation and recruiting phagocytes, CD8+ T cells, and NK cells in CL.
  • Th17 cells promote macrophage differentiation, B cell expansion, and Treg cell development, influencing both acute and chronic phases.
  • Inflammatory infiltrates modulate Th17 cell differentiation and expansion via cytokines like IL-1β, TGF-β, IL-6, and IL-21.

Conclusions:

  • Th17 cell activity is essential for early resistance against Leishmania infection.
  • Dysregulated Th17 cell responses and their interplay with inflammatory cells can drive the transition of CL to a chronic stage.